Tag: lupus

Olympic Athletes Vulnerable to Everyday Health Risks

On the field of play, Olympic athletes appear to be superhuman ― stronger, faster, and fitter than the rest of us ― and in picture-perfect...

Lupus Images Fall Short in Diversity

Lupus images in medical resource materials underrepresent patients with skin of color, based on data from a review of more than 1,400 images published between...

Challenges Persist in Move to Adult Care for Rheumatic Diseases

The inadequacies and challenges of transitioning pediatric rheumatology patients to adult care were highlighted in several research studies shared at the annual scientific meeting of...

Rituximab Benefits Seen in Neuropsychiatric Lupus

Patients with neuropsychiatric manifestations of systemic lupus erythematosus (NPSLE) seem to benefit from rituximab (Rituxan) therapy, according to data from the British Isles Lupus Assessment...

Renal, CV Damage May Develop in Mild SLE Despite Treatment

Patients with mild to moderate systemic lupus erythematosus (SLE) disease activity without any past history of organ damage may still progress to develop damage, particularly...

Nearly 20% of Lupus Patients Have Severe Infection in First Decade After Diagnosis

People with systemic lupus erythematosus (SLE) experienced significantly higher rates of first severe infections, a higher number of severe infections overall, and greater infection-related mortality,...

Maternal Chronic Conditions Predict Cerebral Palsy in Offspring

Several maternal chronic conditions increase the risk of giving birth to a child with cerebral palsy, based on data from more than 1.3 million Norwegian...

Slow Taper off Antimalarial Avoids Lupus Flare During Remission

Slowly tapering off – or remaining on – antimalarial medications can help prevent disease flare in patients with systemic lupus erythematosus (SLE) who’ve achieved clinical...

Lupus-Specific Predictors for CVD Described in Black Patients

Black patients with systemic lupus erythematosus (SLE) are known to have significantly elevated risk for stroke and ischemic heart disease (IHD), compared with non-Black patients...

COVID-19-Related HCQ Shortages Affected Rheum Patients Worldwide

New data document the global fallout for rheumatology patients when hydroxychloroquine (HCQ) supplies were being diverted to hospitals for COVID-19 patients. Demand for HCQ soared...

Promising Drugs Line Up for Lupus Treatment

Systemic lupus erythematosus remains a treatment challenge, but a variety of drugs in the pipeline are set to target type I interferons, cytokines, and B...

The Long Road to a PsA Prevention Trial

About one-third of all patients with psoriasis will develop psoriatic arthritis (PsA), a condition that comes with a host of vague symptoms and no definitive...

COVID-19 Ills No Greater for Those With Lupus, RA

By Robert Preidt HealthDay Reporter FRIDAY, Sept. 4, 2020 (HealthDay News) — People with lupus aren’t at increased risk of hospitalization from COVID-19 due to...

What We Know and Don’t Know

Right now, my workup includes nasal swab PCR for COVID, and IgG and IgM serology if available. We have IgG easily...

ACR Releases Guidance on Rheumatic Diseases During Pandemic

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. When COVID-19 is suspected or confirmed in a patient with a...

More Hydroxychloroquine Data From France

I agree with this argument when it comes to patients presenting with risk factors or who are starting to develop pneumonia. But I don’t...